FBXL7 silencing inhibits proliferation, migration, and invasion of glioma cells and sensitizes glioma cells and ovarian cancer cells resistant to chemotherapeutic drugs [17, 35]. This evidence concerns the gene FBXL7 and central nervous system cancer.